NCHPEG and the American Medical Association (AMA) have released a free Web-based educational program designed to improve the primary care provider’s ability to identify hereditary colorectal cancer syndromes in their patients. This program focuses on case-based learning through a series of clinical scenarios that apply point-of-care tools to key clinical roles in risk assessment, genetic testing, communication, and management. The program also provides access to the point-of-care tools as downloadable pdfs for use in patient care.
“With rapidly developing advances in genetic and molecular medicine, physicians are seeking ways to stay up-to-date in this field to better serve their patients,” said AMA President Jeremy A. Lazarus, M.D. “These developments have made it possible for physicians to now identify hereditary cancer syndromes by looking for specific clues in a patient’s personal and family medical history. We created this educational program to help physicians identify, evaluate, communicate with and manage patients at increased risk for colorectal cancer.”
Colorectal cancer affects approximately 140,000 individuals annually in the U.S. Like other cancers, it develops due to a combination of genetic, biologic and environmental factors interacting together. Approximately 5-10 percent of colorectal cancers are caused by a hereditary syndrome in which a single gene alteration conveys a high risk of colorectal and sometimes other cancers. Individuals suspected to have a hereditary cancer syndrome can sometimes be offered genetic testing to aid in the diagnosis.
“Physicians and other health providers often need information and tools to integrate genetics into their practice,” said NCHPEG Executive Director Joan Scott, M.S., C.G.C. “We developed this program to allow providers to learn as they apply skills through working through cases. They leave the program with knowledge, skills and easily accessible point-of-care tools they can use with their patients.”
This course is available freely available to all users. CME is available in both an enduring, traditional format and a performance improvement format. The enduring format of the course has been certified for 6.0 AMA PRA Category 1 CreditsTM, while participants who complete all three stages of the performance improvement format are eligible for 20.0 AMA PRA Category 1 CreditsTM.
This program was funded by Myriad Genetics, VHA Contract #VA200P0034, AMA, and Humana.
Interested in taking the program? The course is available in both an enduring format and a performance improvement format for CME credit. Individuals who do not plan to apply for CME should register for the enduring course. Click on the links to read more about each option and register.
- A dedicated service for the Management of Hereditary Colorectal Cancer Improves Adherence with Molecular Testing for Lynch Syndrome (familyhistorybowelcancer.wordpress.com)
- Preoperative Testing For Lynch Syndrome Yields ‘Huge’ Benefit (familyhistorybowelcancer.wordpress.com)
- EGAPP™ Recommendation Statement: Genetic testing for Lynch Syndrome (familyhistorybowelcancer.wordpress.com)
- JAMA: Identification of Lynch Syndrome Among Patients With Colorectal Cancer (familyhistorybowelcancer.wordpress.com)
- Life-Saving DNA Test Overlooked in Rise of Colon Cancer: Bloomberg News (familyhistorybowelcancer.wordpress.com)
- New, Free Continuing Education for Nurses: Preventing Colorectal Cancer (prweb.com)